Journals / Güncel Pediatri / 2010 / Cilt: 8 - Sayı: 2

Brain natriuretic peptide and applications in pediatrics

Beyin natriüretik peptid ve pediatride kullanım alanları

Pages
67–71
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Natriüretic peptide family seems to be a “novel candidate marker” for the assessment of diagnosis, therapeutic response and prognosis in cardiovascular disease. (Journal of Current Pediatrics 2010; 8: 67-71)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Family of natriuretic peptides (NP), consists of eight or more peptides associated with each other.
📊
Key Findings & Data:These are, atrial natriuretic peptide (ANP) prohormone consisting of 126 amino acids; brain natriuretic peptide (BNP) prohormone consisting of 108 amino acids; C-type natriuretic peptide (CNP) prohormone consisting of 126 amino acids.
💡
Conclusion & Impact:Natriüretic peptide family seems to be a “novel candidate marker” for the assessment of diagnosis, therapeutic response and prognosis in cardiovascular disease. (Journal of Current Pediatrics 2010; 8: 67-71)
🔬Design:Research Article
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Family of natriuretic peptides (NP), consists of eight or more peptides associated with each other. These are, atrial natriuretic peptide (ANP) prohormone consisting of 126 amino acids; brain natriuretic peptide (BNP) prohormone consisting of 108 amino acids; C-type natriuretic peptide (CNP) prohormone consisting of 126 amino acids. Although recently identified, natriuretic peptides have potential clinical significance. Natriüretic peptide family seems to be a “novel candidate marker” for the assessment of diagnosis, therapeutic response and prognosis in cardiovascular disease. (Journal of Current Pediatrics 2010; 8: 67-71)

Özet

Natriüretik peptid ailesi (NP), sekiz ve daha fazla birbiriyle ilişkili peptidi içermektedir. Bunlar, 126 aminoasitten oluşan atrial natriüretik peptid (ANP) prohormonu, 108 aminoasitten oluşan brain natriüretik peptid (BNP) prohormonu, ve 126 aminoasitten oluşan C tipi natriüretik peptid (CNP) prohormonudur. Natriüretik peptidler son zamanlarda tanımlanmış olmalarına karşın potansiyel klinik öneme sahiptirler. Natriüretik peptidler, kardiyovasküler hastalıkların tanısı, tedaviye yanıtın ve prognozun değerlendirilmesinde yeni aday markerlardır. (Güncel Pediatri 2010; 8: 67-71)

🔖

Cite This Article

OYGÜR, N., AKCAN, A. B. (2022). Brain natriuretic peptide and applications in pediatrics. Güncel Pediatri, Cilt: 8 - Sayı: 2, 67–71. https://ajindex.com/articles/528072

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Witthaut R. Science review: natriuretic peptides in critical illness. Crit Care 2004;8:342-9
  2. Abassi Z, Karram T, Ellaham S, Winaver J, Hoffman A. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance. Pharmacol Ther 2004;102:223-41
  3. Mair J, Hammerer-Lercher A, Puschendorf B. The impact of cardiac natriüretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med 2001;39:571-88
  4. Levin ER, Gardner DG, Samson WK. Natriüretic peptides. N Engl J Med 1998;339:321-28
  5. Nasser N, Bar-OzB, Nir A. Natriuretic peptides and heart disease in infants and children. J Pediatr 2005;147:248-53
  6. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature 1988;332:78-81
  7. Mukoyama M, Nakao K, Hosoda K, Suqa S, Saito Y, Oqawa Y et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991;87:1402-12
  8. Sudoh T, Minamino N, Kangawa K, Matsuo H. C-type natriuretic peptide (CNP). A new member of the natriuretic peptide family identified in porcine brain. Biochem Biophys Research Commun 1990;168:863-80
  9. Naruko T, Ueda M, van der Wal AC, van der Loos CM, Itoh H, Nakao K et al. C-type natriuretic peptide expression in human coronary atherosclerotic lesions. Circulation 1996;94:3103-8
  10. Komatsu Y, Nakao K, Itoh H, Suga S, Ogawa Y, Imura H. Vascular natriuretic peptide. Lancet 1992;340:622
  11. Maeda K, Tsuramoto T, Wada A, Hisanaga Y, Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998;135:825-32
  12. Clerico A, Del Ry S, Giannessi D. Measurement of cardiac natriuretic hormones (atrial natriuretic peptide, brain natriuretic peptide, and related peptides) in clinical practice: the need for a new generation of immunoassay methods. Clin Chem 2006;46:1529-34
  13. Maisel AS, Koon J, Krishnaswamy P, Kazeneqra R, Clopton P, Gardetto N et al. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J 2001;141:367-74
  14. Cowie MR, Mendez GF. BNP and congestive heart failure. Prog Cardiovasc Dis 2002;44:293-321
  15. Nakamura T, Sakamoto K, Yam